Review highlights pharmacological effects of Pandanus amaryllifolius in metabolic syndrome, suggesting new therapeutic potentials.
Background: An interesting medicinal plant in Southeast Asia, Pandanus amaryllifolius Roxb. (P. amaryllifolius) is used as a flavouring and in Southeast Asian folk medicine to treat a range of illnesses. Objective: An overview of research on the phytochemistry and pharmacological effects of P. amaryllifolius is the goal of this paper. Method: This review was based on an analysis of scientific literature sourced from various electronic databases, including PubMed, ScienceDirect, Google Scholar, Web of Science, and Scopus. Result: Pandamarilactonine-A and -B, pandanamine, pandamarilactone-1, and pandamarilactone-32 are among the primary chemical compounds extracted and identified from P. amaryllifolius. Norpandamarilactonines C and D, pandalizine C, pandalizine D, pandalizine E, pandanusine A, pandanusine B, and pandamarilactone-3. The potential pharmacological effects of P. amaryllifolius include hepatoprotective, antiviral, anticancer, antibacterial, and antihyperglycemic effects in the context of metabolic syndrome. Conclusion: P. amaryllifolius may be used to treat various diseases; however, insufficient studies have been conducted on the phytochemistry of the plant. As a result, more research should concentrate on drug development, P. amaryllifolius leaf toxicity testing, and the isolation and identification of active compounds.
No takes yet. Share an insight, caveat, or question.
Pamungkas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: